€21.80
Your prediction
Financial data and news for Discovery
sharewise wants to provide you with the best news and tools for Discovery, so we directly link to the best financial data sources.
Financials
News
Why Warner Bros. Discovery Stock Tumbled Today
Shares of Warner Bros. Discovery (NASDAQ: WBD) were heading lower today on reports that its TNT cable network was expected to lose the rights to air the NBA in the latest auction.
Separately, the
Why Warner Bros. Discovery Stock Was Falling Today
Shares of Warner Bros. Discovery (NASDAQ: WBD) were heading lower today after the video entertainment giant posted disappointing results in its fourth quarter as revenue and profits both declined
1 Artificial Intelligence (AI) Stock to Buy Hand Over Fist in January
More than 500 years ago, the Age of Discovery began as famous explorers crossed the oceans and opened new trade routes connecting the Americas, Africa, Asia, and Europe.
And it all happened because
The Nasdaq-100 Just Had Its Best Year Since 1999: Here Are 3 Stocks Wall Street Thinks Will Soar Another 29% or More in 2024
Party like it's 1999: That's what many stocks in the Nasdaq-100 did in 2023. The index delivered its biggest gains since the end of the 20th century, skyrocketing nearly 54%.
The sizzling momentum
Can a Warner Bros. Discovery and Disney Bundle Fend Off Netflix?
Media and entertainment giant Warner Bros. Discovery Inc. (NASDAQ: WBD) shares initially tanked to $7.50 on its Q1 2024 earnings results. But the consumer discretionary sector giant recovered
Warner Bros. Discover: Debt down, profits up, yet questions remain
Warner Bros. Discovery (NASDAQ: WBD) is the media and entertainment sector powerhouse born from the 2022 merger of WarnerMedia and Discovery. Warner Bros. Discovery’s earnings report for Q4 2023
Corbus Pharmaceuticals stock: An explosive 342% YTD surge
Shares of Corbus Pharmaceuticals (NASDAQ: CRBP) have already experienced a meteoric rise of over 300% year-to-date. This is thanks to fresh news released two Fridays ago, on January 26. The
GNQ Insilico's AI-Driven Digital Twin Platform Shows Promising Results in First Virtually Simulated Clinical Drug Trial
- GNQ Insilico's ("GNQ") proprietary genomics-driven platform is leveraging Artificial Intelligence (AI) and Quantum Computing technologies to create "intelligent digital twins" of
